We encourage our employees to dream

Then we give them the freedom to reach those dreams

Otsuka

We create innovations for the WORLD

Our Products

Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, and nephrology. OCPI is dedicated to improving patients’ health and the quality of human life.

^PrABILIFY® (aripiprazole)

^PrABILIFY MAINTENA® (aripiprazole)

^PrJINARC® (tolvaptan)

^PrREXULTI® (brexpiprazole)

^PrSAMSCA® (tolvaptan)

^PrTAVNEOS® (avacopan)

^PrVELPHORO® (sucroferric oxyhydroxide)

^PrVELTASSA® (patiromer)

Careers

Start a new Story at Otsuka

Come and work with a team of people who aren’t afraid to challenge convention. This approach can lead to something new, something better.

We aspire to attract best-in-class people and partners. After all, having the right team makes all the difference.

We encourage our employees to dream. Then we give them the freedom to reach for those dreams.

What is your story going to be?

VIEW ALL CAREERS

News

April 14, 2022

Otsuka Canada Pharmaceutical Inc. announces Health Canada approval of TAVNEOS^® (avacopan) for ANCA-Associated Vasculitis
-Health Canada approved the first orally-administered inhibitor of the complement 5a receptor – for the treatment of two types of ANCA-associated vasculitis (GPA and MPA), a debilitating disease with significant unmet medical needs-